Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Pbi-shRNA™ EWS/FLI1 Type 1 Lipoplex (LPX) in Subjects With Advanced Ewing's Sarcoma

NCT02736565 is registered in ClinicalTrials.gov with Gradalis, Inc. as lead sponsor.

NCT NCT02736565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02736565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Pbi-shRNA™ EWS/FLI1 Type 1 Lipoplex (LPX) in Subjects With Advanced Ewing's Sarcoma
Lead sponsor
Gradalis, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2016
Completion date
August 4, 2020
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ewing family of tumors, ewing's sarcoma, ewing's sarcoma metastatic, ewing's tumor metastatic, ewing's tumor recurrent, rare diseases, sarcoma